Multiplexed proteomics and predictive drug candidate assessment
AssigneeThe General Hospital Corporation
InventorsWilhelm Haas, Cyril Benes
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorsWilhelm Haas, Cyril Benes
Estimating the term…
The disclosure features methods of identifying specific drug candidates for disease treatment, the methods including: for pairs of associated expressed proteins in a protein-protein interaction network for a plurality of biological samples, comparing relative concentration values of the associated proteins in each of the biological samples to identify outliers among a distribution of the relative concentration values, identifying a set of proteins involved in dysregulated protein-protein interactions in the network based on the outliers, and predicting an efficacy of one or more drug candidates from among a set of drug candidates for treating a disease based on the identified set of proteins and information about one or more of proteins, protein complexes, biological pathways, and functional modules targeted by the set of drug candidates.
A method of identifying specific drug candidates for disease treatment, the method comprising:
A computer program product tangibly embodying a set of instructions that, when executed by a processor, causes the processor to identify specific drug candidates for disease treatment by:
Dependencies are inferred from the claim text.